Companies

Acrivon Therapeutics, Inc. (ACRV) SEC filings

CIK 0001781174 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023
Net income (USD)-77.9 M-60.4 M-31.2 M
Diluted EPS (USD/shares)-2.02-2.74-7.56

Latest filings

FiledFormDescriptionPeriod
2026-10-074FORM 42026-10-05
2026-09-024FORM 42026-08-31
2026-09-023FORM 32026-08-31
2026-08-274FORM 42026-08-25
2026-08-25144144
2026-08-204FORM 42026-08-18
2026-08-204FORM 42026-08-18
2026-08-204FORM 42026-08-18
2026-08-204FORM 42026-08-18
2026-08-204FORM 42026-08-18
2026-08-13SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-12S-8S-8
2026-08-128-K8-K items 2.02,9.012026-08-12
2026-08-1210-Q10-Q2026-06-30
2026-08-064FORM 42026-08-04
2026-07-234FORM 42026-07-21
2026-06-22442026-06-17
2026-06-224FORM 42026-06-17
2026-06-224FORM 42026-06-17
2026-06-224FORM 42026-06-17
2026-06-224FORM 42026-06-17
2026-06-224FORM 42026-06-17
2026-06-224FORM 42026-06-17
2026-06-178-K8-K items 5.02,5.07,9.012026-06-17
2026-05-264FORM 42026-05-21

Forms on file (last 1,000): 4 183, 8-K 43, 3 21, 10-Q 12, SC 13G/A 10, S-8 8, SCHEDULE 13G/A 7, DEFA14A 5. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=ACRV (0.002 USD), /gw/filings/filings?ticker=ACRV&form=8-K, /gw/filings/facts?ticker=ACRV&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange